This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Alex J. Novak, PhD
Concord, NH

JAMA. 1991;265(22):2961.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Krumholz et al¹ high-light the often arbitrary standards regarding driving and epilepsy. But laws are being forged that would allow no detectable levels of agents with adverse central nervous system action, ie, that can impair the ability of the person to operate a motor vehicle safely, in the system (adapted from the California Vehicle Code, section 312).

Surely, the physician faces a dilemma. He or she is to provide adequate control of seizures, on the one hand, and to avoid potentially impairing remedies, on the other. All antiepileptic agents share at least some of the following untoward effects: ataxia, blurred vision, confusion, day blindness, diplopia, dizziness, and drowsiness. Certainly, until tolerance develops, any of these could reduce driving skills. How can physicians and their patients with epilepsy deal with zero-tolerance laws? . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?